Exploring BMP9 and integrin alpha 10 as novel chondrogenic markers in human bone marrow-derived mesenchymal stem cells, chondroprogenitors, and chondrocytes: an immunohistochemistry study
{"title":"Exploring BMP9 and integrin alpha 10 as novel chondrogenic markers in human bone marrow-derived mesenchymal stem cells, chondroprogenitors, and chondrocytes: an immunohistochemistry study","authors":"Mohana Priya , Ayshath Ruksana C , Christo Jeyaraj , Archa Suresh , Ganesh Parasuraman , Grace Rebekah , Elizabeth Vinod","doi":"10.1016/j.knee.2025.09.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Evaluating cartilage repair potential involves subjecting the cellular 3D pellets to chondrogenic differentiation and assessing their differentiation degree using immunohistochemical (IHC) studies. Collagen type II IHC staining stands as a key marker to evaluate mature chondrogenesis, but its non-uniform staining confounded by incomplete differentiation necessitates exploring alternative markers. This study explored the potential of BMP9 and Integrin Alpha 10 as novel early-stage chondrogenic markers in human bone marrow-derived mesenchymal stem cells (BM-MSCs), fibronectin assay derived chondroprogenitors (FAA-CPs), migratory chondroprogenitors (MCPs) and chondrocytes following differentiation.</div></div><div><h3>Methods</h3><div>Three human articular cartilage samples and bone marrow aspirate from osteoarthritis patients were collected to isolate the BM-MSCs, FAA-CPs, MCPs and chondrocytes. Following their molecular characterization, differentiation assays were conducted followed by their confirmatory staining and IHC for BMP9 and Integrin alpha10.</div></div><div><h3>Result</h3><div>IHC analysis collagen type II revealed positive with a non-uniform pattern of expression. The same sections subjected to integrin alpha 10 IHC analysis exhibited a greater proportion of uptake and a more uniform distribution throughout the differentiated pellet, addressing a key limitation observed with ECM and collagen staining techniques. The spatial homogeneity observed could be attributed to the functional relevance of integrin alpha 10, a Collagen type II receptor which mediates cell-matrix interactions and is specifically expressed in chondrocytes, further underscoring its potential as an alternative marker. However, BMP9 did not display robust staining.</div></div><div><h3>Conclusion</h3><div>Integrin alpha 10 may serve as a valuable alternative or complementary marker to collagen type II for assessing chondrogenic differentiation, offering a more consistent spatial distribution.</div></div>","PeriodicalId":56110,"journal":{"name":"Knee","volume":"57 ","pages":"Pages 311-324"},"PeriodicalIF":2.0000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Knee","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968016025002431","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Evaluating cartilage repair potential involves subjecting the cellular 3D pellets to chondrogenic differentiation and assessing their differentiation degree using immunohistochemical (IHC) studies. Collagen type II IHC staining stands as a key marker to evaluate mature chondrogenesis, but its non-uniform staining confounded by incomplete differentiation necessitates exploring alternative markers. This study explored the potential of BMP9 and Integrin Alpha 10 as novel early-stage chondrogenic markers in human bone marrow-derived mesenchymal stem cells (BM-MSCs), fibronectin assay derived chondroprogenitors (FAA-CPs), migratory chondroprogenitors (MCPs) and chondrocytes following differentiation.
Methods
Three human articular cartilage samples and bone marrow aspirate from osteoarthritis patients were collected to isolate the BM-MSCs, FAA-CPs, MCPs and chondrocytes. Following their molecular characterization, differentiation assays were conducted followed by their confirmatory staining and IHC for BMP9 and Integrin alpha10.
Result
IHC analysis collagen type II revealed positive with a non-uniform pattern of expression. The same sections subjected to integrin alpha 10 IHC analysis exhibited a greater proportion of uptake and a more uniform distribution throughout the differentiated pellet, addressing a key limitation observed with ECM and collagen staining techniques. The spatial homogeneity observed could be attributed to the functional relevance of integrin alpha 10, a Collagen type II receptor which mediates cell-matrix interactions and is specifically expressed in chondrocytes, further underscoring its potential as an alternative marker. However, BMP9 did not display robust staining.
Conclusion
Integrin alpha 10 may serve as a valuable alternative or complementary marker to collagen type II for assessing chondrogenic differentiation, offering a more consistent spatial distribution.
期刊介绍:
The Knee is an international journal publishing studies on the clinical treatment and fundamental biomechanical characteristics of this joint. The aim of the journal is to provide a vehicle relevant to surgeons, biomedical engineers, imaging specialists, materials scientists, rehabilitation personnel and all those with an interest in the knee.
The topics covered include, but are not limited to:
• Anatomy, physiology, morphology and biochemistry;
• Biomechanical studies;
• Advances in the development of prosthetic, orthotic and augmentation devices;
• Imaging and diagnostic techniques;
• Pathology;
• Trauma;
• Surgery;
• Rehabilitation.